Executives On The Move: Changes At AbCellera Biologics, Decibel Therapeutics And More
C-Suite changes at AbCellera Biologics and promotions at Lyell Immunopharma are among recent executive moves in the industry. Meanwhile, new directors were appointed at Decibel Therapeutics, Curis and Ventus Therapeutics, among others.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Recent executive changes in the industry include the appointment of a new CEO at Medivir and promotions at Idorsia. Meanwhile, new directors were appointed at Reneo Pharmaceuticals, among others.
Coronavirus Update: As Pfizer/BioNTech Begin Omicron Vaccine Tests, Regulators Want To Explore Multivalent Route
Pfizer explores options for new vaccine update, Veklury expands to non-hospitalized patients but Regeneron and Lilly therapies stopped in face of Omicron efficacy drop-off.